Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lipocine Inc LPCN

Healthcare
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor... see more

Recent & Breaking News (NDAQ:LPCN)

10 Biggest Mid-Day Gainers For Friday

Benzinga.com  October 7, 2016

Mid-Day Market Update: Dow Drops Over 100 Points; Gap Shares Rise Following September Sales Numbers

Benzinga.com  October 7, 2016

Mid-Morning Market Update: Markets Open Lower; Silicon Motion Raises Q3 Forecast

Benzinga.com  October 7, 2016

Research Reports Coverage on Generic Drugs Stocks -- SCYNEXIS, Supernus Pharma, Lipocine, and Carbylan Therapeutics

PR Newswire October 5, 2016

Mid-Afternoon Market Update: Dow Falls 150 Points; Himax Technologies Shares Slide After Nomura Downgrade

Benzinga.com  September 26, 2016

Mid-Day Market Update: Crude Oil Up 3.3%; Chemtura Shares Surge Following Acquisition News

Benzinga.com  September 26, 2016

Lipocine Announces Positive Top-Line Phase 2b Study Results for LPCN 1111, a Next Generation Oral Testosterone Replacement Therapy

GlobeNewswire September 26, 2016

Lipocine to Present at 2016 Ladenburg Thalmann Healthcare Conference

GlobeNewswire September 20, 2016

DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN

GlobeNewswire August 29, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 – LPCN

GlobeNewswire August 24, 2016

SHAREHOLDER ALERT: Rosen Law Firm Reminds Lipocine Inc. Investors of Important August 30 Deadline in Class Action Filed by Firm - LPCN

GlobeNewswire August 22, 2016

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline: August 30, 2016

GlobeNewswire August 22, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016

Business Wire August 19, 2016

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Lipocine Inc. Of Upcoming Deadline

GlobeNewswire August 18, 2016

GPM Reminds Investors of the August 30th Deadline in the Class Action Lawsuit Against Lipocine Inc. and Encourages Investors to Contact the Firm

Business Wire August 17, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016

Business Wire August 15, 2016

Lipocine Announces Financial and Operational Results for the Second Quarter of 2016

GlobeNewswire August 9, 2016

Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors with Losses from Investment in Lipocine Inc. to Contact the Firm

Business Wire August 8, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016

Business Wire August 5, 2016

Lipocine to Present at 36th Annual Canaccord Genuity Growth Conference

GlobeNewswire August 4, 2016